Cargando…
Association of soluble suppression of tumorigenicity 2 protein with new-onset atrial fibrillation in patients with acute ST-segment elevation myocardial infarction undergoing primary PCI
BACKGROUND: Previous studies have indicated that the soluble suppression of tumorigenicity 2 protein (sST2) is associated with new-onset atrial fibrillation (NOAF) in patients diagnosed with coronary artery disease (CAD). However, the predictive value of sST2 in patients with acute ST-segment elevat...
Autores principales: | Zhao, Ting-ting, Pan, Tian-jiao, Yang, Yi-bo, Pei, Xiao-yang, Wang, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551440/ https://www.ncbi.nlm.nih.gov/pubmed/37808879 http://dx.doi.org/10.3389/fcvm.2023.1207219 |
Ejemplares similares
-
Triglyceride-Glucose Index and New-Onset Atrial Fibrillation in ST-Segment Elevation Myocardial Infarction Patients After Percutaneous Coronary Intervention
por: Ling, Yang, et al.
Publicado: (2022) -
Comparison of outcomes in ST-segment depression and ST-segment elevation myocardial infarction patients treated with emergency PCI: data from a multicentre registry
por: Knot, Jiri, et al.
Publicado: (2012) -
Circulating Soluble Suppression of Tumorigenicity 2 Predicts Recurrence After Radiofrequency Ablation of Persistent Atrial Fibrillation
por: Tan, Ruopeng, et al.
Publicado: (2021) -
When the bomb is inside the heart: atrial myxoma presenting as ST-segment elevation myocardial infarction
por: Fernández de-Aspe, Pablo, et al.
Publicado: (2020) -
New-Onset Atrial Fibrillation in St-Segment Elevation Myocardial Infarction: Predictors and Impact on Therapy And Mortality
por: Congo, Kisa Hyde, et al.
Publicado: (2019)